Travere Therapeutics Inc — 四半期財務統計 (NASDAQ:TVTX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -35.72 M-42.19 M4.98 M14.32 M60.68 M 37.78 M 投資活動によるキャッシュフロー -80.31 M41.29 M4.85 M86.59 M-104.84 M 27.89 M 財務活動によるキャッシュフロー 139.12 M3.72 M1.48 M-65.34 M26.68 M -33.47 M フリーキャッシュフロー -45.36 M-53.98 M-7.1 M-871 K41.44 M -20.51 M

ニュース

Stock Market Hits Highs On Iran Hopes; Goldman Sachs, Netflix, Taiwan Semiconductor In Focus: Weekly Review

Four Biotech Stocks Near Buy Points As Earnings Season Kicks In

Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?

Stock Market Leaders Emerge In IBD 50, Rise In Volume After Follow-Through Day

Travere Therapeutics: Re-Rating Potential As Filspari Wins Full Approval (NASDAQ:TVTX)

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

Travere (TVTX) Soars 37.2%: Is Further Upside Left in the Stock?

Stocks Rally on a Push for Diplomacy to End US-Iran War

Stocks Rally on US-Iran Peace Hopes and Cooler PPI Growth

Stocks Climb on US-Iran Peace Talk Optimism and a Favorable PPI Report

Travere Therapeutics Stock Skyrockets On Highly Anticipated FDA Approval

Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS Transcript